Usage de Cannabis chez les sujets à ultra-haut risque de psychose

La consommation de cannabis est très répandue chez les sujets à ultra-haut risque (UHR) de psychose. Le lien causal ainsi que le lien temporel entre la consommation de cannabis et la survenue ultérieure de psychose chez les sujets UHR demeurent non concluants. Les données actuelles de la science éta...

Full description

Saved in:
Bibliographic Details
Published inLa Presse médicale (1983) Vol. 48; no. 11; pp. 1229 - 1236
Main Authors Fekih-Romdhane, Feten, Hakiri, Abir, Fadhel, Sinda Ben, Cheour, Majda
Format Journal Article
LanguageFrench
Published Elsevier Masson SAS 01.11.2019
Online AccessGet full text

Cover

Abstract La consommation de cannabis est très répandue chez les sujets à ultra-haut risque (UHR) de psychose. Le lien causal ainsi que le lien temporel entre la consommation de cannabis et la survenue ultérieure de psychose chez les sujets UHR demeurent non concluants. Les données actuelles de la science étaient en faveur d’un risque augmenté de survenue ultérieure de psychose chez les sujets consommateurs de cannabis qui sont génétiquement prédisposés à la psychose. Ce risque serait encore plus important en présence d’une histoire familiale de psychose, d’une forte consommation et d’un âge jeune de début de consommation. Plusieurs modèles ont été cités pour expliquer le lien entre le cannabis et la survenue ultérieure de psychose ou d’états prépsychotiques : les modifications de certaines structures cérébrales induites par le cannabis, un dérèglement de l’axe hypothalamo-hypophysaire et une altération du développement neurologique normal via le système endocannabinoide. Le cannabis représente un facteur de risque modifiable de psychose. Les interventions actuelles visent à réduire ou à arrêter la consommation de cannabis afin de réduire le risque de transition vers la psychose. Cannabis use is widespread among people at ultra-high risk (UHR) for psychosis. The causal link as well as the temporal link between cannabis use and further occurrence of psychosis in UHR people remain inconclusive. Current science data supported an increased risk of transition to psychosis in cannabis users who are genetically predisposed to psychosis. This risk would be even greater in the presence of a family history of psychosis, in case of a strong use and an early onset use. Several models have been cited to explain the link between cannabis use and the subsequent onset of psychosis or prepsychotic states: cannabis-induced modifications of some brain structures, a dysregulation of the hypothalamic-pituitary axis and an alteration of normal neurological development via the endocannabinoid system. Cannabis represents a modifiable risk for psychosis. Current interventions aim to reduce or stop the cannabis use in order to reduce the risk of transition to psychosis.
AbstractList La consommation de cannabis est très répandue chez les sujets à ultra-haut risque (UHR) de psychose. Le lien causal ainsi que le lien temporel entre la consommation de cannabis et la survenue ultérieure de psychose chez les sujets UHR demeurent non concluants. Les données actuelles de la science étaient en faveur d’un risque augmenté de survenue ultérieure de psychose chez les sujets consommateurs de cannabis qui sont génétiquement prédisposés à la psychose. Ce risque serait encore plus important en présence d’une histoire familiale de psychose, d’une forte consommation et d’un âge jeune de début de consommation. Plusieurs modèles ont été cités pour expliquer le lien entre le cannabis et la survenue ultérieure de psychose ou d’états prépsychotiques : les modifications de certaines structures cérébrales induites par le cannabis, un dérèglement de l’axe hypothalamo-hypophysaire et une altération du développement neurologique normal via le système endocannabinoide. Le cannabis représente un facteur de risque modifiable de psychose. Les interventions actuelles visent à réduire ou à arrêter la consommation de cannabis afin de réduire le risque de transition vers la psychose. Cannabis use is widespread among people at ultra-high risk (UHR) for psychosis. The causal link as well as the temporal link between cannabis use and further occurrence of psychosis in UHR people remain inconclusive. Current science data supported an increased risk of transition to psychosis in cannabis users who are genetically predisposed to psychosis. This risk would be even greater in the presence of a family history of psychosis, in case of a strong use and an early onset use. Several models have been cited to explain the link between cannabis use and the subsequent onset of psychosis or prepsychotic states: cannabis-induced modifications of some brain structures, a dysregulation of the hypothalamic-pituitary axis and an alteration of normal neurological development via the endocannabinoid system. Cannabis represents a modifiable risk for psychosis. Current interventions aim to reduce or stop the cannabis use in order to reduce the risk of transition to psychosis.
Author Hakiri, Abir
Fadhel, Sinda Ben
Fekih-Romdhane, Feten
Cheour, Majda
Author_xml – sequence: 1
  givenname: Feten
  surname: Fekih-Romdhane
  fullname: Fekih-Romdhane, Feten
  email: feten@doctor.com
  organization: Hôpital Razi, service de psychiatrie Ibn-Omrane, 1, rue des orangers, 2010 La-Manouba, Tunisie
– sequence: 2
  givenname: Abir
  surname: Hakiri
  fullname: Hakiri, Abir
  organization: Hôpital Razi, service de psychiatrie Ibn-Omrane, 1, rue des orangers, 2010 La-Manouba, Tunisie
– sequence: 3
  givenname: Sinda Ben
  surname: Fadhel
  fullname: Fadhel, Sinda Ben
  organization: Hôpital Razi, service de psychiatrie Ibn-Omrane, 1, rue des orangers, 2010 La-Manouba, Tunisie
– sequence: 4
  givenname: Majda
  surname: Cheour
  fullname: Cheour, Majda
  organization: Hôpital Razi, service de psychiatrie Ibn-Omrane, 1, rue des orangers, 2010 La-Manouba, Tunisie
BookMark eNp9kEFOwzAQRS1UJNrCAdj5AgljJ45jsYIKClIlNmVtOc6EOkqTYidI5TTchYuRUlYsKn1pNIv3pf9mZNJ2LRJyzSBmwLKbOm5225gDUzGMSeCMTDlnSQRcZhMyBSlElKqcX5BZCDUAZ6lUU3L_Gswb0hLpwrStKVygdoOftMFAw1BjH-j3Fx2a3ptoY4aeehfeh19gF_Z20wW8JOeVaQJe_d05WT8-rBdP0epl-by4W0WWpRwiVVolRMWzXGKRpFkpigJYzoucV0kmSy6YMAWqw5ujqSphrAGJykCJViZzwo611ncheKz0zrut8XvNQB8c6FqPDvTBgYYxCYyM_MdY15vede24xzUnydsjieOiD4deB-uwtVg6j7bXZedO0D_A93mY
CitedBy_id crossref_primary_10_1016_j_lpmfor_2020_08_011
crossref_primary_10_4236_ajps_2020_1112139
crossref_primary_10_1186_s12888_024_05727_x
crossref_primary_10_1186_s12888_023_04942_2
crossref_primary_10_1007_s11469_024_01337_6
crossref_primary_10_1186_s13034_024_00825_w
Cites_doi 10.1016/S2215-0366(16)30188-2
10.1017/S0033291713000433
10.1176/appi.ajp.2007.07071110
10.1016/j.biopsych.2012.06.020
10.1111/j.1360-0443.2005.01001.x
10.1016/j.psyneuen.2017.04.017
10.1093/schbul/sbp016
10.1017/S0033291714000117
10.1111/acps.12382
10.1016/j.schres.2016.08.026
10.1111/j.1600-0447.2010.01640.x
10.1007/s40429-014-0018-7
10.1007/s00213-008-1422-2
10.1111/acps.12699
10.1016/j.biopsych.2016.01.011
10.1046/j.1440-1614.2000.00685.x
10.1001/archpsyc.65.6.694
10.1093/aje/kwf043
10.1177/070674370605100903
10.1111/pcn.12085
10.4088/JCP.09r05119gry
10.1016/j.schres.2006.03.014
10.1007/s11920-002-0026-5
10.1002/j.2051-5545.2011.tb00036.x
10.1136/bmj.325.7374.1212
10.1017/S0033291715000227
10.3389/fpsyt.2013.00128
10.1093/schbul/sbt181
10.1016/j.encep.2016.02.014
10.1017/S0033291709990729
10.1017/S0033291716002671
10.1177/0004867415599846
10.1146/annurev.clinpsy.4.022007.141248
10.1093/schbul/sbs188
10.1017/S0033291702006384
10.1136/bmj.38267.664086.63
10.1016/j.pneurobio.2010.06.010
10.1111/eip.12112
10.1016/j.psychres.2006.10.001
10.1371/journal.pone.0070378
10.1111/eip.12100
10.1016/j.encep.2013.12.003
10.3109/00048670903487118
10.1111/j.1600-0447.2011.01763.x
ContentType Journal Article
Copyright 2019 Elsevier Masson SAS
Copyright_xml – notice: 2019 Elsevier Masson SAS
DBID AAYXX
CITATION
DOI 10.1016/j.lpm.2019.09.030
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Cannabis use in subjects at ultra high risk for psychosis
EISSN 2213-0276
EndPage 1236
ExternalDocumentID 10_1016_j_lpm_2019_09_030
S075549821930418X
GroupedDBID --M
.~1
08J
08T
0R~
1~.
3O-
4.4
457
4G.
53G
5VS
7-5
8P~
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABFNM
ABLVK
ABMAC
ABOCM
ABXDB
ABYKQ
ACDAQ
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
EBS
EFJIC
EFLBG
EJD
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
J1W
KOM
LCYCR
MO0
N9A
O-L
O9-
OAUVE
P-8
P-9
PC.
Q38
SDF
SEM
SES
SJN
SPCBC
SSH
SSZ
T5K
ZXP
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACIEU
ACRPL
ADNMO
AEIPS
AFJKZ
AFOST
AGCQF
AGRNS
AIIUN
ANKPU
APXCP
CITATION
SHL
ID FETCH-LOGICAL-c1420-9dc955f2687eb346d5bb0182b82f367d2515abe982f38eaff5aca07e9a0dec73
IEDL.DBID .~1
ISSN 0755-4982
IngestDate Thu Apr 24 22:55:10 EDT 2025
Tue Jul 01 01:32:43 EDT 2025
Fri Feb 23 02:49:09 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Language French
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1420-9dc955f2687eb346d5bb0182b82f367d2515abe982f38eaff5aca07e9a0dec73
PageCount 8
ParticipantIDs crossref_primary_10_1016_j_lpm_2019_09_030
crossref_citationtrail_10_1016_j_lpm_2019_09_030
elsevier_sciencedirect_doi_10_1016_j_lpm_2019_09_030
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2019
2019-11-00
PublicationDateYYYYMMDD 2019-11-01
PublicationDate_xml – month: 11
  year: 2019
  text: November 2019
PublicationDecade 2010
PublicationTitle La Presse médicale (1983)
PublicationYear 2019
Publisher Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
References Hall, Degenhardt (bib0285) 2000; 34
Verdoux, Gindre, Sorbara, Tournier, Swendsen (bib0315) 2003; 33
UNODC. World Drug Report 2013. Crime UNOoDa, UNODC 2013. United Nation on Drugs and Crime, United Nations publication, Sales No. E.13.XI.6.
Volkow (bib0485) 2009; 35
De Hert, Cohen, Bobes, Cetkovich-Bakmas, Leucht, Ndetei (bib0250) 2011; 10
Degenhardt, Hall (bib0300) 2006; 51
Clausen, Hjorthoj, Thorup, Jeppesen, Petersen, Bertelsen (bib0470) 2014; 44
Pruessner, Cullen, Aas, Walker (bib0450) 2017; 73
Rais, Cahn, Van, Schnak, Caspers, Hulshoff (bib0415) 2008; 165
Walker, Mittal, Tessner (bib0445) 2008; 4
Yung, Stanford, Cosgrave, Killackey, Phillips, Nelson (bib0265) 2006; 84
Gill, Poe, Azimov, Ben-David, Vadhan, Girgis (bib0290) 2015; 9
Stefanis, Dragovic, Power, Jablensky, Castle, Morgan (bib0395) 2013; 39
Carney, Yung, Amminger, Bradshaw, Glozier, Hermens (bib0475) 2016; 181
Sherif, Radhakrishnan, D'Souza, Ranganathan (bib0320) 2016; 79
Burns (bib0335) 2013; 4
Yücel, Solowij, Respondek (bib0410) 2008; 65
Fergusson, Horwood, Ridder (bib0350) 2005; 100
Baker, Hides, Lubman (bib0480) 2010; 71
Kuepper, Ceccarini, Lataster, van Os, van Kroonenburgh, van Gerven (bib0435) 2013; 8
Carney, Cotter, Firth, Bradshaw, Yung (bib0330) 2017; 136
O’donoghue, McHugh, Nelson, McGorry (bib0390) 2017
Van Os, Bak, Hanssen, Bijl, de Graaf, Verdoux (bib0325) 2002; 6
McHugh, McGorry, Yung, Lin, Wood, Hartmann (bib0385) 2017; 47
Henquet, Krabbendam, Spauwen, Kaplan, Lieb, Wittchen (bib0420) 2005; 330
Degenhardt, Hall (bib0305) 2002; 4
Carol, Spencer, Mittal (bib0440) 2017; 83
Myles, Myles, Large (bib0255) 2016; 50
Krebs, Magaud, Willard, Elkhazen, Chauchot, Gut (bib0275) 2014; 40
Buchy, Cadenhead, Cannon, Cornblatt, McGlashan, Perkins (bib0280) 2015; 45
Martin-Santos, Fagundo, Crippa, Bhattachayya, Allen, Fusar Foli (bib0455) 2010; 40
Wilkinson, Radhakrishnan, D'Souza (bib0345) 2014; 1
Arseneault, Cannon, Poulton, Murray, Caspi, Moffitt (bib0355) 2002; 325
Degenhardt, Hall (bib0310) 2001; 31
Di Forti, Iyegbe, Sallis, Kolliakou, Falcone, Paparelli (bib0425) 2012; 72
Fusar-Poli, Borgwardt, Bechdolf, Addington, Riecher-Rössler, Schultze-Lutter (bib0270) 2013; 70
Ranganathan, Braley, Pittman, Cooper, Perry, Krystal (bib0460) 2009; 203
Schoeler, Petros, Di Forti, Klamerus, Foglia, Ajnakina (bib0490) 2016; 3
Rocchetti, Crescini, Borgwardt, Caverzasi, Politi, Atakan (bib0430) 2013; 67
Dragt, Nieman, Schultze-Lutter, van der Meer, Becker, de Haan (bib0365) 2012; 125
Kristensen, Cadenhead (bib0380) 2007; 151
Benarous, Gauthier, Lôo (bib0295) 2017; 43
Di Forti, Sallis, Allegri, Trotta, Ferraro, Stilo (bib0340) 2014; 40
Auther, Cadenhead, Carrión, Addington, Bearden, Cannon (bib0370) 2015; 132
Bossong, Niesink (bib0405) 2010; 92
Addington, Case, Saleem, Auther, Cornblatt, Cadenhead (bib0260) 2014; 8
Valmaggia, Day, Jones, Bissoli, Pugh, Hall (bib0375) 2014; 44
Korver, Nieman, Becker, van de Fliert, Dingemans, de Haan (bib0465) 2010; 44
Schubart, Boks, Breetvelt, Van Gastel, Groenwold, Ophoff (bib0360) 2011; 123
Pruessner (10.1016/j.lpm.2019.09.030_bib0450) 2017; 73
Fusar-Poli (10.1016/j.lpm.2019.09.030_bib0270) 2013; 70
Auther (10.1016/j.lpm.2019.09.030_bib0370) 2015; 132
Korver (10.1016/j.lpm.2019.09.030_bib0465) 2010; 44
Rais (10.1016/j.lpm.2019.09.030_bib0415) 2008; 165
Degenhardt (10.1016/j.lpm.2019.09.030_bib0305) 2002; 4
Sherif (10.1016/j.lpm.2019.09.030_bib0320) 2016; 79
Hall (10.1016/j.lpm.2019.09.030_bib0285) 2000; 34
Di Forti (10.1016/j.lpm.2019.09.030_bib0425) 2012; 72
Burns (10.1016/j.lpm.2019.09.030_bib0335) 2013; 4
Walker (10.1016/j.lpm.2019.09.030_bib0445) 2008; 4
Fergusson (10.1016/j.lpm.2019.09.030_bib0350) 2005; 100
De Hert (10.1016/j.lpm.2019.09.030_bib0250) 2011; 10
Arseneault (10.1016/j.lpm.2019.09.030_bib0355) 2002; 325
Schubart (10.1016/j.lpm.2019.09.030_bib0360) 2011; 123
Martin-Santos (10.1016/j.lpm.2019.09.030_bib0455) 2010; 40
Benarous (10.1016/j.lpm.2019.09.030_bib0295) 2017; 43
Buchy (10.1016/j.lpm.2019.09.030_bib0280) 2015; 45
Stefanis (10.1016/j.lpm.2019.09.030_bib0395) 2013; 39
Di Forti (10.1016/j.lpm.2019.09.030_bib0340) 2014; 40
Gill (10.1016/j.lpm.2019.09.030_bib0290) 2015; 9
Wilkinson (10.1016/j.lpm.2019.09.030_bib0345) 2014; 1
Rocchetti (10.1016/j.lpm.2019.09.030_bib0430) 2013; 67
Degenhardt (10.1016/j.lpm.2019.09.030_bib0310) 2001; 31
Kristensen (10.1016/j.lpm.2019.09.030_bib0380) 2007; 151
Kuepper (10.1016/j.lpm.2019.09.030_bib0435) 2013; 8
10.1016/j.lpm.2019.09.030_bib0400
O’donoghue (10.1016/j.lpm.2019.09.030_bib0390) 2017
Van Os (10.1016/j.lpm.2019.09.030_bib0325) 2002; 6
McHugh (10.1016/j.lpm.2019.09.030_bib0385) 2017; 47
Verdoux (10.1016/j.lpm.2019.09.030_bib0315) 2003; 33
Bossong (10.1016/j.lpm.2019.09.030_bib0405) 2010; 92
Yücel (10.1016/j.lpm.2019.09.030_bib0410) 2008; 65
Krebs (10.1016/j.lpm.2019.09.030_bib0275) 2014; 40
Schoeler (10.1016/j.lpm.2019.09.030_bib0490) 2016; 3
Carney (10.1016/j.lpm.2019.09.030_bib0475) 2016; 181
Yung (10.1016/j.lpm.2019.09.030_bib0265) 2006; 84
Carol (10.1016/j.lpm.2019.09.030_bib0440) 2017; 83
Dragt (10.1016/j.lpm.2019.09.030_bib0365) 2012; 125
Myles (10.1016/j.lpm.2019.09.030_bib0255) 2016; 50
Addington (10.1016/j.lpm.2019.09.030_bib0260) 2014; 8
Volkow (10.1016/j.lpm.2019.09.030_bib0485) 2009; 35
Carney (10.1016/j.lpm.2019.09.030_bib0330) 2017; 136
Valmaggia (10.1016/j.lpm.2019.09.030_bib0375) 2014; 44
Clausen (10.1016/j.lpm.2019.09.030_bib0470) 2014; 44
Baker (10.1016/j.lpm.2019.09.030_bib0480) 2010; 71
Ranganathan (10.1016/j.lpm.2019.09.030_bib0460) 2009; 203
Henquet (10.1016/j.lpm.2019.09.030_bib0420) 2005; 330
Degenhardt (10.1016/j.lpm.2019.09.030_bib0300) 2006; 51
References_xml – volume: 72
  start-page: 811
  year: 2012
  end-page: 816
  ident: bib0425
  article-title: Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
  publication-title: Biol Psychiatry
– volume: 71
  start-page: 247
  year: 2010
  end-page: 254
  ident: bib0480
  article-title: Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review
  publication-title: J Clin Psychiatry
– volume: 44
  start-page: 230
  year: 2010
  end-page: 236
  ident: bib0465
  article-title: Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls
  publication-title: Aust N Z J Psychiatry
– volume: 33
  start-page: 23
  year: 2003
  end-page: 32
  ident: bib0315
  article-title: Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study
  publication-title: Psychol Med
– volume: 4
  start-page: 189
  year: 2008
  end-page: 216
  ident: bib0445
  article-title: Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia
  publication-title: Ann Rev of Clin Psychol
– volume: 40
  start-page: 1509
  year: 2014
  end-page: 1517
  ident: bib0340
  article-title: Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users
  publication-title: Schizophr Bull
– volume: 136
  start-page: 5
  year: 2017
  end-page: 15
  ident: bib0330
  article-title: Cannabis use and symptom severity in individuals at ultra-high risk for psychosis: a meta-analysis
  publication-title: Acta Psychiatr Scand
– volume: 181
  start-page: 23
  year: 2016
  end-page: 29
  ident: bib0475
  article-title: Substance use in youth at risk for psychosis
  publication-title: Schizophr Res
– volume: 35
  start-page: 469
  year: 2009
  end-page: 472
  ident: bib0485
  article-title: Substance use disorders in schizophrenia – clinical implications of comorbidity
  publication-title: Schizophr Bull
– volume: 40
  start-page: 383
  year: 2010
  end-page: 398
  ident: bib0455
  article-title: Neuroimaging in cannabis use: a systematic review of the literature
  publication-title: Psychol Med
– volume: 73
  start-page: 191
  year: 2017
  end-page: 218
  ident: bib0450
  article-title: The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci and Bio behav Rev
– volume: 10
  start-page: 138
  year: 2011
  ident: bib0250
  article-title: Physical illness in patients with severe mental disorders II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
  publication-title: World Psych
– volume: 70
  start-page: 107
  year: 2013
  end-page: 120
  ident: bib0270
  article-title: The psychosis high-risk state: a comprehensive state-of-the-art review
  publication-title: JAMA
– volume: 44
  start-page: 2503
  year: 2014
  end-page: 2512
  ident: bib0375
  article-title: Cannabis use and transition to psychosis in people at ultra-high risk
  publication-title: Psychol Med
– start-page: 167
  year: 2017
  end-page: 181
  ident: bib0390
  article-title: Effects of Cannabis Use in Those at Ultra-High Risk for Psychosis
  publication-title: The Complex Connection Between Cannabis and Schizophrenia
– volume: 65
  start-page: 694
  year: 2008
  end-page: 701
  ident: bib0410
  article-title: Regional brain abnormalities associated with long-term heavy cannabis use
  publication-title: Arch Gen Psychiatry
– reference: UNODC. World Drug Report 2013. Crime UNOoDa, UNODC 2013. United Nation on Drugs and Crime, United Nations publication, Sales No. E.13.XI.6.
– volume: 92
  start-page: 370
  year: 2010
  end-page: 385
  ident: bib0405
  article-title: Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
  publication-title: Prog Neurobiol
– volume: 79
  start-page: 526
  year: 2016
  end-page: 538
  ident: bib0320
  article-title: Human laboratory studies on cannabinoids and psychosis
  publication-title: Biol Psychiatry
– volume: 84
  start-page: 57
  year: 2006
  end-page: 66
  ident: bib0265
  article-title: Testing the ultra-high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people
  publication-title: Schizophr Res
– volume: 43
  start-page: 399
  year: 2017
  end-page: 401
  ident: bib0295
  article-title: Symptômes thymiques lors de l’émergence d’un trouble psychotique à l’adolescence: à propos d’un cas
  publication-title: L’Encéphale
– volume: 6
  start-page: 319
  year: 2002
  end-page: 327
  ident: bib0325
  article-title: Cannabis use and psychosis: a longitudinal population-based study
  publication-title: Am J Epidemiol
– volume: 44
  start-page: 117
  year: 2014
  end-page: 126
  ident: bib0470
  article-title: Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial
  publication-title: Psychol Med
– volume: 8
  start-page: 104
  year: 2014
  end-page: 112
  ident: bib0260
  article-title: Substance use in clinical high risk for psychosis: a review of the literature
  publication-title: Early Interv Psychiatry
– volume: 67
  start-page: 483
  year: 2013
  end-page: 492
  ident: bib0430
  article-title: Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users
  publication-title: Psychiatry Clin Neurosci
– volume: 45
  start-page: 2275
  year: 2015
  end-page: 2284
  ident: bib0280
  article-title: Substance use in individuals at clinical high risk of psychosis
  publication-title: Psychol Med
– volume: 31
  start-page: 659
  year: 2001
  end-page: 668
  ident: bib0310
  article-title: The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-being
  publication-title: Psychol
– volume: 50
  start-page: 208
  year: 2016
  end-page: 219
  ident: bib0255
  article-title: Cannabis use in first episode psychosis: meta-analysis of prevalence, and the time course of initiation and continued use
  publication-title: Aust N Z J Psychiatry
– volume: 1
  start-page: 115
  year: 2014
  end-page: 128
  ident: bib0345
  article-title: Impact of Cannabis Use on the Development of Psychotic Disorders
  publication-title: Curr Addict Rep
– volume: 132
  start-page: 60
  year: 2015
  end-page: 68
  ident: bib0370
  article-title: Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
  publication-title: Acta Psychiatr Scand
– volume: 123
  start-page: 368
  year: 2011
  end-page: 375
  ident: bib0360
  article-title: Association between cannabis and psychiatric hospitalization
  publication-title: Acta Psychiatr Scand
– volume: 125
  start-page: 45
  year: 2012
  end-page: 53
  ident: bib0365
  article-title: Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
  publication-title: Acta Psychiatr Scand
– volume: 47
  start-page: 616
  year: 2017
  end-page: 626
  ident: bib0385
  article-title: Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis
  publication-title: Psychol Med
– volume: 325
  start-page: 1212
  year: 2002
  end-page: 1213
  ident: bib0355
  article-title: Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
  publication-title: Br Med J
– volume: 8
  start-page: e70378
  year: 2013
  ident: bib0435
  article-title: Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study
  publication-title: PLoS ONE
– volume: 34
  start-page: 26
  year: 2000
  end-page: 34
  ident: bib0285
  article-title: Cannabis use and psychosis: a review of clinical and epidemiological evidence
  publication-title: Aust N Z J Psychiatry
– volume: 4
  start-page: 128
  year: 2013
  ident: bib0335
  article-title: Pathways from cannabis to psychosis: a review of the evidence
  publication-title: Front Psychiatry
– volume: 40
  start-page: 447
  year: 2014
  end-page: 456
  ident: bib0275
  article-title: Évaluation des états mentaux à risque de transition psychotique : validation de la version française de la CAARMS
  publication-title: Encéphale
– volume: 39
  start-page: 251
  year: 2013
  end-page: 254
  ident: bib0395
  article-title: Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend
  publication-title: Schizophr Bull
– volume: 51
  start-page: 556
  year: 2006
  end-page: 565
  ident: bib0300
  article-title: Is cannabis use a contributory cause of psychosis?
  publication-title: Can J Psychiatry
– volume: 4
  start-page: 191
  year: 2002
  end-page: 196
  ident: bib0305
  article-title: Cannabis and psychosis
  publication-title: Curr Psychiatry Rep
– volume: 165
  start-page: 490
  year: 2008
  end-page: 496
  ident: bib0415
  article-title: Excessive brain volume loss over time in cannabis-using first-episod schizophrenia patients
  publication-title: Am J Psychiatry
– volume: 83
  start-page: 58
  year: 2017
  end-page: 64
  ident: bib0440
  article-title: The relationship between cannabis use and cortisol levels in youth at ultra-high-risk for psychosis
  publication-title: Psychoneuroendocrinology
– volume: 330
  start-page: 11
  year: 2005
  end-page: 14
  ident: bib0420
  article-title: Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
  publication-title: BMJ
– volume: 9
  start-page: 207
  year: 2015
  end-page: 210
  ident: bib0290
  article-title: Reasons for cannabis use among youths at ultra high risk for psychosis
  publication-title: Early Interv Psychiatry
– volume: 203
  start-page: 737
  year: 2009
  end-page: 744
  ident: bib0460
  article-title: The effects of cannabinoids on serum cortisol and prolactin in humans
  publication-title: Psychopharmacol
– volume: 100
  start-page: 354
  year: 2005
  end-page: 366
  ident: bib0350
  article-title: Tests of causal linkages between cannabis use and psychotic symptoms
  publication-title: Addiction
– volume: 151
  start-page: 151
  year: 2007
  end-page: 154
  ident: bib0380
  article-title: Cannabis abuse and risk for psychosis in a prodromal sample
  publication-title: Psychiatry Res
– volume: 3
  start-page: 947
  year: 2016
  end-page: 953
  ident: bib0490
  article-title: Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study
  publication-title: Lancet Psychiatry
– volume: 3
  start-page: 947
  year: 2016
  ident: 10.1016/j.lpm.2019.09.030_bib0490
  article-title: Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(16)30188-2
– volume: 44
  start-page: 117
  issue: 1
  year: 2014
  ident: 10.1016/j.lpm.2019.09.030_bib0470
  article-title: Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial
  publication-title: Psychol Med
  doi: 10.1017/S0033291713000433
– volume: 165
  start-page: 490
  year: 2008
  ident: 10.1016/j.lpm.2019.09.030_bib0415
  article-title: Excessive brain volume loss over time in cannabis-using first-episod schizophrenia patients
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2007.07071110
– volume: 72
  start-page: 811
  year: 2012
  ident: 10.1016/j.lpm.2019.09.030_bib0425
  article-title: Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2012.06.020
– volume: 100
  start-page: 354
  year: 2005
  ident: 10.1016/j.lpm.2019.09.030_bib0350
  article-title: Tests of causal linkages between cannabis use and psychotic symptoms
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2005.01001.x
– volume: 83
  start-page: 58
  year: 2017
  ident: 10.1016/j.lpm.2019.09.030_bib0440
  article-title: The relationship between cannabis use and cortisol levels in youth at ultra-high-risk for psychosis
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2017.04.017
– volume: 35
  start-page: 469
  year: 2009
  ident: 10.1016/j.lpm.2019.09.030_bib0485
  article-title: Substance use disorders in schizophrenia – clinical implications of comorbidity
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp016
– volume: 70
  start-page: 107
  year: 2013
  ident: 10.1016/j.lpm.2019.09.030_bib0270
  article-title: The psychosis high-risk state: a comprehensive state-of-the-art review
  publication-title: JAMA
– volume: 44
  start-page: 2503
  year: 2014
  ident: 10.1016/j.lpm.2019.09.030_bib0375
  article-title: Cannabis use and transition to psychosis in people at ultra-high risk
  publication-title: Psychol Med
  doi: 10.1017/S0033291714000117
– volume: 132
  start-page: 60
  year: 2015
  ident: 10.1016/j.lpm.2019.09.030_bib0370
  article-title: Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/acps.12382
– volume: 181
  start-page: 23
  year: 2016
  ident: 10.1016/j.lpm.2019.09.030_bib0475
  article-title: Substance use in youth at risk for psychosis
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2016.08.026
– volume: 123
  start-page: 368
  issue: 5
  year: 2011
  ident: 10.1016/j.lpm.2019.09.030_bib0360
  article-title: Association between cannabis and psychiatric hospitalization
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/j.1600-0447.2010.01640.x
– volume: 1
  start-page: 115
  issue: 2
  year: 2014
  ident: 10.1016/j.lpm.2019.09.030_bib0345
  article-title: Impact of Cannabis Use on the Development of Psychotic Disorders
  publication-title: Curr Addict Rep
  doi: 10.1007/s40429-014-0018-7
– volume: 203
  start-page: 737
  year: 2009
  ident: 10.1016/j.lpm.2019.09.030_bib0460
  article-title: The effects of cannabinoids on serum cortisol and prolactin in humans
  publication-title: Psychopharmacol
  doi: 10.1007/s00213-008-1422-2
– volume: 136
  start-page: 5
  issue: 1
  year: 2017
  ident: 10.1016/j.lpm.2019.09.030_bib0330
  article-title: Cannabis use and symptom severity in individuals at ultra-high risk for psychosis: a meta-analysis
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/acps.12699
– volume: 79
  start-page: 526
  issue: 7
  year: 2016
  ident: 10.1016/j.lpm.2019.09.030_bib0320
  article-title: Human laboratory studies on cannabinoids and psychosis
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2016.01.011
– volume: 34
  start-page: 26
  issue: 1
  year: 2000
  ident: 10.1016/j.lpm.2019.09.030_bib0285
  article-title: Cannabis use and psychosis: a review of clinical and epidemiological evidence
  publication-title: Aust N Z J Psychiatry
  doi: 10.1046/j.1440-1614.2000.00685.x
– volume: 65
  start-page: 694
  issue: 6
  year: 2008
  ident: 10.1016/j.lpm.2019.09.030_bib0410
  article-title: Regional brain abnormalities associated with long-term heavy cannabis use
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.65.6.694
– volume: 6
  start-page: 319
  issue: 4
  year: 2002
  ident: 10.1016/j.lpm.2019.09.030_bib0325
  article-title: Cannabis use and psychosis: a longitudinal population-based study
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwf043
– volume: 51
  start-page: 556
  issue: 9
  year: 2006
  ident: 10.1016/j.lpm.2019.09.030_bib0300
  article-title: Is cannabis use a contributory cause of psychosis?
  publication-title: Can J Psychiatry
  doi: 10.1177/070674370605100903
– volume: 67
  start-page: 483
  issue: 7
  year: 2013
  ident: 10.1016/j.lpm.2019.09.030_bib0430
  article-title: Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users
  publication-title: Psychiatry Clin Neurosci
  doi: 10.1111/pcn.12085
– volume: 71
  start-page: 247
  year: 2010
  ident: 10.1016/j.lpm.2019.09.030_bib0480
  article-title: Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.09r05119gry
– volume: 84
  start-page: 57
  year: 2006
  ident: 10.1016/j.lpm.2019.09.030_bib0265
  article-title: Testing the ultra-high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2006.03.014
– volume: 4
  start-page: 191
  issue: 3
  year: 2002
  ident: 10.1016/j.lpm.2019.09.030_bib0305
  article-title: Cannabis and psychosis
  publication-title: Curr Psychiatry Rep
  doi: 10.1007/s11920-002-0026-5
– volume: 10
  start-page: 138
  issue: 2
  year: 2011
  ident: 10.1016/j.lpm.2019.09.030_bib0250
  article-title: Physical illness in patients with severe mental disorders II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
  publication-title: World Psych
  doi: 10.1002/j.2051-5545.2011.tb00036.x
– volume: 325
  start-page: 1212
  year: 2002
  ident: 10.1016/j.lpm.2019.09.030_bib0355
  article-title: Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
  publication-title: Br Med J
  doi: 10.1136/bmj.325.7374.1212
– volume: 45
  start-page: 2275
  year: 2015
  ident: 10.1016/j.lpm.2019.09.030_bib0280
  article-title: Substance use in individuals at clinical high risk of psychosis
  publication-title: Psychol Med
  doi: 10.1017/S0033291715000227
– volume: 31
  start-page: 659
  year: 2001
  ident: 10.1016/j.lpm.2019.09.030_bib0310
  article-title: The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-being
  publication-title: Psychol
– volume: 4
  start-page: 128
  year: 2013
  ident: 10.1016/j.lpm.2019.09.030_bib0335
  article-title: Pathways from cannabis to psychosis: a review of the evidence
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2013.00128
– volume: 40
  start-page: 1509
  year: 2014
  ident: 10.1016/j.lpm.2019.09.030_bib0340
  article-title: Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbt181
– volume: 43
  start-page: 399
  issue: 4
  year: 2017
  ident: 10.1016/j.lpm.2019.09.030_bib0295
  article-title: Symptômes thymiques lors de l’émergence d’un trouble psychotique à l’adolescence: à propos d’un cas
  publication-title: L’Encéphale
  doi: 10.1016/j.encep.2016.02.014
– volume: 40
  start-page: 383
  issue: 3
  year: 2010
  ident: 10.1016/j.lpm.2019.09.030_bib0455
  article-title: Neuroimaging in cannabis use: a systematic review of the literature
  publication-title: Psychol Med
  doi: 10.1017/S0033291709990729
– volume: 47
  start-page: 616
  year: 2017
  ident: 10.1016/j.lpm.2019.09.030_bib0385
  article-title: Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis
  publication-title: Psychol Med
  doi: 10.1017/S0033291716002671
– volume: 50
  start-page: 208
  year: 2016
  ident: 10.1016/j.lpm.2019.09.030_bib0255
  article-title: Cannabis use in first episode psychosis: meta-analysis of prevalence, and the time course of initiation and continued use
  publication-title: Aust N Z J Psychiatry
  doi: 10.1177/0004867415599846
– volume: 4
  start-page: 189
  year: 2008
  ident: 10.1016/j.lpm.2019.09.030_bib0445
  article-title: Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia
  publication-title: Ann Rev of Clin Psychol
  doi: 10.1146/annurev.clinpsy.4.022007.141248
– volume: 39
  start-page: 251
  year: 2013
  ident: 10.1016/j.lpm.2019.09.030_bib0395
  article-title: Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbs188
– volume: 33
  start-page: 23
  year: 2003
  ident: 10.1016/j.lpm.2019.09.030_bib0315
  article-title: Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study
  publication-title: Psychol Med
  doi: 10.1017/S0033291702006384
– ident: 10.1016/j.lpm.2019.09.030_bib0400
– volume: 330
  start-page: 11
  year: 2005
  ident: 10.1016/j.lpm.2019.09.030_bib0420
  article-title: Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
  publication-title: BMJ
  doi: 10.1136/bmj.38267.664086.63
– volume: 92
  start-page: 370
  issue: 3
  year: 2010
  ident: 10.1016/j.lpm.2019.09.030_bib0405
  article-title: Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
  publication-title: Prog Neurobiol
  doi: 10.1016/j.pneurobio.2010.06.010
– volume: 9
  start-page: 207
  issue: 3
  year: 2015
  ident: 10.1016/j.lpm.2019.09.030_bib0290
  article-title: Reasons for cannabis use among youths at ultra high risk for psychosis
  publication-title: Early Interv Psychiatry
  doi: 10.1111/eip.12112
– volume: 151
  start-page: 151
  year: 2007
  ident: 10.1016/j.lpm.2019.09.030_bib0380
  article-title: Cannabis abuse and risk for psychosis in a prodromal sample
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2006.10.001
– volume: 8
  start-page: e70378
  issue: 7
  year: 2013
  ident: 10.1016/j.lpm.2019.09.030_bib0435
  article-title: Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0070378
– volume: 8
  start-page: 104
  year: 2014
  ident: 10.1016/j.lpm.2019.09.030_bib0260
  article-title: Substance use in clinical high risk for psychosis: a review of the literature
  publication-title: Early Interv Psychiatry
  doi: 10.1111/eip.12100
– volume: 73
  start-page: 191
  year: 2017
  ident: 10.1016/j.lpm.2019.09.030_bib0450
  article-title: The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci and Bio behav Rev
– volume: 40
  start-page: 447
  issue: 6
  year: 2014
  ident: 10.1016/j.lpm.2019.09.030_bib0275
  article-title: Évaluation des états mentaux à risque de transition psychotique : validation de la version française de la CAARMS
  publication-title: Encéphale
  doi: 10.1016/j.encep.2013.12.003
– volume: 44
  start-page: 230
  issue: 3
  year: 2010
  ident: 10.1016/j.lpm.2019.09.030_bib0465
  article-title: Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls
  publication-title: Aust N Z J Psychiatry
  doi: 10.3109/00048670903487118
– volume: 125
  start-page: 45
  year: 2012
  ident: 10.1016/j.lpm.2019.09.030_bib0365
  article-title: Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/j.1600-0447.2011.01763.x
– start-page: 167
  year: 2017
  ident: 10.1016/j.lpm.2019.09.030_bib0390
  article-title: Effects of Cannabis Use in Those at Ultra-High Risk for Psychosis
  publication-title: The Complex Connection Between Cannabis and Schizophrenia
SSID ssj0021479
Score 2.0985062
Snippet La consommation de cannabis est très répandue chez les sujets à ultra-haut risque (UHR) de psychose. Le lien causal ainsi que le lien temporel entre la...
SourceID crossref
elsevier
SourceType Enrichment Source
Index Database
Publisher
StartPage 1229
Title Usage de Cannabis chez les sujets à ultra-haut risque de psychose
URI https://dx.doi.org/10.1016/j.lpm.2019.09.030
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JSwMxFA6lgngRV6xLycGTMHaWZCZzrEWpSnuxhd6GrNgy1NKZuXjwt_hf_GO-zFIU1IMwlwzvhfAleQt5C0KXvqE61kQ7fugrh2jJHcY94ghJfCKloKasWzAah8MpeZjRWQsNmlwYG1ZZy_5KppfSuv7Tq9Hsrebz3hMoO3BuGFw5cMk9NrMZ7CSyp_z6bRPmYdvwlCYwEDuWunnZLGO80pVNRvfiqtSp-7Nu-qJv7vbQbm0o4n61ln3UMusDtD2qn8IP0c3UhoRhpfGAL5dczDMM-L_iVGc4KxY6z_DHOy7SfM2dZ17kGG4z6ADLUGVeZfoITe5uJ4OhUzdEcKRHwM2LlYwpNX7IIvCBSaioEC44CIL5JggjBbYK5ULHdsg0N4Zyyd1Ix9xVWkbBMWovX5b6BGEWBoFnqCEwGRFMcaWNYaG01WMEj4IOchskElkXC7c9K9KkiQpbJABeYsFLXPgCt4OuNiyrqlLGX8SkgTf5tt0JSPLf2U7_x3aGduyoSiE8R-18XegLsCVy0S0PSxdt9e8fh-NPLrnJIw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZKkYAF8RTl6YEJKTQPO3FGqKgKtF1opW6R7diiVRWqJlkY-C38F_4Y5zwqkIABKUuSu8g6517yd3cIXbqaqlARZbm-G1tESW4x7hBLSOISKQXVRd-CwdDvjcnDhE4aqFPXwhhYZWX7S5teWOvqSbuSZnsxnbafwNlBcsNA5SAld9hkDa0TUF8zxuD6bYXzMHN4ihgYqC1DXh9tFiCv-cJUozth2evU_tk5fXE43R20XUWK-KZczC5q6OUe2hhUZ-H76HZsMGE4VrjDk4SLaYphA17xXKU4zWcqS_HHO87n2ZJbzzzPMKgzOAHDUJZepeoAjbp3o07PqiYiWNIhkOeFsQwp1a7PAkiCiR9TIWzIEARztecHMQQrlAsVmlumuNaUS24HKuR2rGTgHaJm8pKoI4SZ73mOpprAx4hgMY-V1syXpn2M4IHXQnYtiUhW3cLN0Ip5VMPCZhEILzLCi2y4PLuFrlYsi7JVxl_EpBZv9G2_IzDlv7Md_4_tAm32RoN-1L8fPp6gLfOmrCc8Rc1smaszCCwycV78OJ_-Fcqx
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Usage+de+Cannabis+chez+les+sujets+%C3%A0+ultra-haut+risque+de+psychose&rft.jtitle=La+Presse+m%C3%A9dicale+%281983%29&rft.au=Fekih-Romdhane%2C+Feten&rft.au=Hakiri%2C+Abir&rft.au=Fadhel%2C+Sinda+Ben&rft.au=Cheour%2C+Majda&rft.date=2019-11-01&rft.pub=Elsevier+Masson+SAS&rft.issn=0755-4982&rft.eissn=2213-0276&rft.volume=48&rft.issue=11&rft.spage=1229&rft.epage=1236&rft_id=info:doi/10.1016%2Fj.lpm.2019.09.030&rft.externalDocID=S075549821930418X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0755-4982&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0755-4982&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0755-4982&client=summon